Yu Yanqiu, Lau Mason M C, Jiang Hui, Lau Joseph T F
Centre for Health Behaviours Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Vaccines (Basel). 2021 Aug 2;9(8):847. doi: 10.3390/vaccines9080847.
Globally, COVID-19 vaccination programs have been rolled out. To inform health promotion, this study investigated the prevalence and associated factors of performance or being scheduled to perform at least one dose of COVID-19 vaccination (PSCV) in a Chinese adult general population.
An anonymous, random telephone survey interviewed 500 adults aged 18-75 in Hong Kong, China from 14-27 May 2021.
The prevalence of PSCV was 21.0%, which was significantly lower among females and those aged ≤30. Positively associated factors of PSCV included perceived protection effect of vaccination, self-perceived physical fitness for vaccination, compulsory COVID-19 testing experience, perceived need to travel, general trust toward the government, and trust toward the governmental vaccination program, while negatively associated factors included perceived low efficacy of vaccination, concerns about side effects, and chronic disease status. Furthermore, the association between sex and PSCV was fully mediated by stronger concern about side effects and lower levels of self-perceived physical fitness for COVID-19 vaccination among females than males.
Moderately low prevalence of COVID-19 vaccination was observed in Hong Kong, where there was no shortage of vaccine supply. To achieve herd immunity, health promotion is greatly warranted and may incorporate messages based on the findings of this study.
在全球范围内,新冠疫苗接种计划已经展开。为了为健康促进提供信息,本研究调查了中国成年普通人群中接种一剂或已安排接种至少一剂新冠疫苗(PSCV)的流行情况及相关因素。
2021年5月14日至27日,在中国香港对500名年龄在18至75岁的成年人进行了一项匿名随机电话调查。
PSCV的流行率为21.0%,在女性和30岁及以下人群中显著较低。PSCV的正相关因素包括对疫苗接种保护效果的感知、自我感觉适合接种疫苗、新冠病毒强制检测经历、有出行需求、对政府的总体信任以及对政府疫苗接种计划的信任,而负相关因素包括对疫苗效力的低感知、对副作用的担忧以及慢性病状况。此外,性别与PSCV之间的关联完全由女性比男性对副作用的更强担忧以及更低的自我感觉适合接种新冠疫苗水平所介导。
在疫苗供应不短缺的香港,观察到新冠疫苗接种率处于中等偏低水平。为实现群体免疫,大力开展健康促进工作很有必要,且可纳入基于本研究结果的信息。